Enric Reverter - Concepedia

Author

Enric Reverter

Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas ORCID

Also Known As

Bartomeu Ramis, Christoph Gassner, E Reverter, E. Reverter, Elvezia Maria Paraboschi, Emanuele Pontali, Enric Reverter, Filipe S. Cardoso, Josep María Nicolás, Rafael de Cid

103

Publications

5.9K

Citations

H-Index

Concepts

All Affiliations

Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas Consorci Institut D'Investigacions Biomediques August Pi I Sunyer Universitat de Barcelona Hospital Clínic de Barcelona European Foundation for the Study of Chronic Liver Failure

About

Enric Reverter is an author at Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas specializing in medicine, hepatology, and liver physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	1.4K
2	Health Sciences	5	5	320
3	Public Health	1	1	14
4	Blood Transplantation	1	1	11
5	Diabetes	1	1	33

Enric Reverter

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis Javier Fernández, Juan Acevedo, Reiner Wiest, Gut	2017	548
A MELD-Based Model to Determine Risk of Mortality Among Patients With Acute Variceal Bleeding Enric Reverter, Puneeta Tandon, Salvador Augustín, Gastroenterology Meld-based ModelPatient SafetySepsisLogistic AnalysisDetermine Risk	2013	386
Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does Not Reduce Rebleeding but Increases Survival in Patients With Cirrhosis Juan G. Abraldeṣ, Càndid Villanueva, Carles Aracil, Gastroenterology Increases SurvivalHepatologyVariceal Rebleeding DoesAcute Liver FailureLiver Transplantation	2016	322
Prognostic factors associated with mortality risk and disease progression in 639 critically ill patients with COVID-19 in Europe: Initial report of the international RISC-19-ICU prospective observational cohort Pedro David Wendel‐Garcia, Thierry Fumeaux, Philippe Guerci, EClinicalMedicine	2020	224
Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension Vincenzo La Mura, Joan Carles Reverter, A. Flores-Arroyo, Gut	2011	175
Assessment of portal hypertension by transient elastography in patients with compensated cirrhosis and potentially resectable liver tumors Elba Llop, Annalisa Berzigotti, María Reig, Journal of Hepatology HepatologyLiver PhysiologyPortal HypertensionCompensated CirrhosisGastroenterology	2011	167
Predicting portal thrombosis in cirrhosis: A prospective study of clinical, ultrasonographic and hemostatic factors Fanny Turón, Ellen G. Driever, Anna Baiges, Journal of Hepatology	2021	149
Role of hepatic vein catheterisation and transient elastography in the diagnosis of idiopathic portal hypertension Susana Seijó, Enric Reverter, Rosa Miquel, Digestive and Liver Disease VaricesHepatologyPortal HypertensionHepatic Vein CatheterisationTransient Elastography	2012	148
Coagulation Failure in Patients With Acute‐on‐Chronic Liver Failure and Decompensated Cirrhosis: Beyond the International Normalized Ratio Annabel Blasi, Andrea Calvo, Verónica Prado, Hepatology	2018	113
Agreement between wedged hepatic venous pressure and portal pressure in non-alcoholic steatohepatitis-related cirrhosis José Ferrusquía‐Acosta, Octavi Bassegoda, Laura Turco, Journal of Hepatology HepatologyLiver PhysiologyPortal HypertensionHepatic Venous PressureGastroenterology	2020	110

Page 1